Other

Loss Contingency Accrual

Boston Scientific Loss Contingency Accrual increased by 2.0% to $306.00M in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 22.4%, from $250.00M to $306.00M. Over 4 years (FY 2020 to FY 2024), Loss Contingency Accrual shows a downward trend with a -13.0% CAGR.

Analysis

StatementBalance Sheet Statement
SectionOther
First reportedQ4 2015
Last reportedQ3 2025
Metric ID: other_loss_contingency_accrual_at_carrying_value

Historical Data

18 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25
Value$617.00M$548.00M$548.00M$509.00M$514.00M$304.00M$443.00M$416.00M$419.00M$407.00M$377.00M$283.00M$251.00M$250.00M$326.00M$316.00M$300.00M$306.00M
QoQ Change—-11.2%+0.0%-7.1%+1.0%-40.9%+45.7%-6.1%+0.7%-2.9%-7.4%-24.9%-11.3%-0.4%+30.4%-3.1%-5.1%+2.0%
YoY Change————-16.7%-44.5%-19.2%-18.3%-18.5%+33.9%-14.9%-32.0%-40.1%-38.6%-13.5%+11.7%+19.5%+22.4%
Range$250.00M – $617.00M
CAGR-15.2%
Avg YoY Growth-12.1%
Median YoY Growth-17.5%

Frequently Asked Questions

What is Boston Scientific's loss contingency accrual?
Boston Scientific (BSX) reported loss contingency accrual of $306.00M in Q3 2025.
How has Boston Scientific's loss contingency accrual changed year-over-year?
Boston Scientific's loss contingency accrual increased by 22.4% year-over-year, from $250.00M to $306.00M.
What is the long-term trend for Boston Scientific's loss contingency accrual?
Over 4 years (2020 to 2024), Boston Scientific's loss contingency accrual has grown at a -13.0% compound annual growth rate (CAGR), from $569.00M to $326.00M.